Skip to content

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07193290
Enrollment
1027
Registered
2025-09-25
Start date
2025-05-13
Completion date
2025-10-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Aging, Hair Care, Skin Microbiome

Brief summary

This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main study endpoints across balanced attributes of study sub-populations.

Interventions

All subjects will complete the lifestyle questionnaire

OTHERSelf-portrait image (Face and Hair)

All subjects will take one self-portrait image of their face and hair

DIAGNOSTIC_TESTSkin microbiome collection

Subjects randomly assigned in the skin microbiome subset will complete the skin microbiome collection

Sponsors

Kenvue Brands LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-reported Monk skin type 1 to 10, targeting to complete at least 100 subjects for each Monk skin type. * 18 to 65 years old, targeting to complete: * 18- to 40-year-old age range: at least 50 subjects within each Monk type * 41- to 65-year-old age range: at least 50 subjects within each Monk type * Lives within an Inner City, Urban, Suburban, or Rural community type (as determined by self-report or provided zip code), targeting to complete: * Inner City/Urban community type: at least 25 subjects within each age range and Monk type * Suburban/Rural community type: at least 25 subjects within each age range and Monk type * Has electronically accepted the Consent for Photograph Release and ICD including Health Insurance Portability and Accountability Act (HIPAA) disclosure. * Has a personal smartphone with a camera and an internet connection (wi-fi, cellular services, etc.). * Intends to complete the study and willing and able to follow all study instructions.

Exclusion criteria

* Has known allergies or adverse reactions to topical adhesives. * Is simultaneously participating in any other clinical study for the duration of this study or has participated in any product-use study within 30 days prior to remote Visit 1. * Is an employee/contractor or immediate family member of the PI, study technology provider, laboratory, or Sponsor.

Design outcomes

Primary

MeasureTime frameDescription
Interaction efficiency (contacted vs. enrolled)4 weeks post Last Subject's remote visitThe number and percentage of subjects who interacted with the digital study activities vs number and percentage of subjects who completed the study.
Percent completion of subject self-taken images4 weeks post Last Subject's remote visitThe number and percentage of subjects who successfully completed the self-taken images.
Percent completion of subjects participating in bio-sampling subset4 weeks post Last Subject's remote visitThe number and percentage of subjects who successfully completed the bio-sampling procedures.

Secondary

MeasureTime frameDescription
Questionnaire results compared across skin tone4 weeks post Last Subject's remote visitThe lifestyle questionnaire results will be summarized by either descriptive analysis or frequency by Monk Skin tone 1 to 10.
Questionnaire results compared across age groups4 weeks post Last Subject's remote visitThe lifestyle questionnaire results will be summarized by either descriptive analysis or frequency by age groups 18- to 40-year-old and 41- to 65-year-old.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026